Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Marco Caminati and Gianenrico Senna.
Marco Caminati
Connection Strength
9.760
Gianenrico Senna
  1. Who Is Really at Risk for Anaphylaxis Due to COVID-19 Vaccine? Vaccines (Basel). 2021 Jan 11; 9(1).
    View in: PubMed
    Score: 0.923
  2. Targeting eosinophils: severe asthma and beyond. Drugs Context. 2019; 8:212587.
    View in: PubMed
    Score: 0.834
  3. Trends and determinants of Emergency Room admissions for asthma: A retrospective evaluation in Northeast Italy. World Allergy Organ J. 2019; 12(7):100046.
    View in: PubMed
    Score: 0.831
  4. New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic. Biologics. 2019; 13:89-95.
    View in: PubMed
    Score: 0.824
  5. Safety of uSCIT-MPL-4: prevalence and risk factors of systemic reactions in real life. Immunotherapy. 2019 06; 11(9):783-794.
    View in: PubMed
    Score: 0.823
  6. Biologic Therapy in a Patient with Asthma and Nasal Polyps. J Allergy Clin Immunol Pract. 2019 May - Jun; 7(5):1700-1701.
    View in: PubMed
    Score: 0.821
  7. Uncontrolled severe asthma: starting from the unmet needs. Curr Med Res Opin. 2019 02; 35(2):175-177.
    View in: PubMed
    Score: 0.793
  8. Serum periostin during omalizumab therapy in asthma: A tool for patient selection and treatment evaluation. Ann Allergy Asthma Immunol. 2017 Nov; 119(5):460-462.
    View in: PubMed
    Score: 0.734
  9. COVID-19 Vaccination in Patients with Severe Asthma on Biologic Treatment: Safety, Tolerability, and Impact on Disease Control. Vaccines (Basel). 2021 Aug 04; 9(8).
    View in: PubMed
    Score: 0.240
  10. Allergy and coronavirus disease (COVID-19) international survey: Real-life data from the allergy community during the pandemic. World Allergy Organ J. 2021 Feb; 14(2):100515.
    View in: PubMed
    Score: 0.232
  11. Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity. Respir Med. 2021 01; 176:106261.
    View in: PubMed
    Score: 0.229
  12. Editorial: Reconsidering anaphylaxis at the time of COVID-19 pandemic. Curr Opin Allergy Clin Immunol. 2020 10; 20(5):429-430.
    View in: PubMed
    Score: 0.226
  13. BCG vaccination and COVID-19: Much ado about nothing? Med Hypotheses. 2020 11; 144:110109.
    View in: PubMed
    Score: 0.223
  14. Asthmatic patients in COVID-19 outbreak: Few cases despite many cases. J Allergy Clin Immunol. 2020 09; 146(3):541-542.
    View in: PubMed
    Score: 0.222
  15. Thunderstorm Asthma: A Critical Appraisal Based on Clinical Practice. J Investig Allergol Clin Immunol. 2018 Aug; 28(4):273-275.
    View in: PubMed
    Score: 0.195
  16. Spontaneous pneumomediastinum complicating severe acute asthma exacerbation in adult patients. J Asthma. 2018 09; 55(9):1028-1034.
    View in: PubMed
    Score: 0.185
  17. Evaluation of asthma control in the pharmacy: an Italian cross-sectional study. Eur Ann Allergy Clin Immunol. 2017 Sep; 49(5):225-230.
    View in: PubMed
    Score: 0.183
  18. Asthma management among allergists in Italy: results from a survey. Clin Mol Allergy. 2017; 15:11.
    View in: PubMed
    Score: 0.179
  19. SANI-Severe Asthma Network in Italy: a way forward to monitor severe asthma. Clin Mol Allergy. 2017; 15:9.
    View in: PubMed
    Score: 0.178
  20. Fatal asthma; is it still an epidemic? World Allergy Organ J. 2016; 9(1):42.
    View in: PubMed
    Score: 0.174
  21. Incidence and risk factors for subcutaneous immunotherapy anaphylaxis: the optimization of safety. Expert Rev Clin Immunol. 2015 Feb; 11(2):233-45.
    View in: PubMed
    Score: 0.151
  22. Anaphylaxis and Coronavirus Disease 2019 vaccine: a danger relationship? Curr Opin Allergy Clin Immunol. 2021 10 01; 21(5):411-417.
    View in: PubMed
    Score: 0.061
  23. Importance of Cardiopulmonary Exercise Testing amongst Subjects Recovering from COVID-19. Diagnostics (Basel). 2021 Mar 12; 11(3).
    View in: PubMed
    Score: 0.058
  24. COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey. Allergy. 2021 03; 76(3):871-874.
    View in: PubMed
    Score: 0.056
  25. Efficacy of mepolizumab in patients with previous omalizumab treatment failure: Real-life observation. Allergy. 2019 12; 74(12):2539-2541.
    View in: PubMed
    Score: 0.052
  26. Prevalence of severe asthma according to the drug regulatory agency perspective: An Italian experience. World Allergy Organ J. 2019; 12(4):100032.
    View in: PubMed
    Score: 0.051
  27. Use of complementary medicine among patients with allergic rhinitis: an Italian nationwide survey. Clin Mol Allergy. 2019; 17:2.
    View in: PubMed
    Score: 0.051
  28. Eosinophilic Granulomatosis With Polyangiitis and Cardiac Involvement: A Case Report. J Investig Allergol Clin Immunol. 2018 Aug; 28(4):285-286.
    View in: PubMed
    Score: 0.049
  29. Prevalence and features of asthma-chronic obstructive pulmonary disease overlap in Northern Italy general population. J Asthma. 2019 01; 56(1):27-33.
    View in: PubMed
    Score: 0.047
  30. Anaphylaxis and intimate behaviour. Curr Opin Allergy Clin Immunol. 2017 Oct; 17(5):350-355.
    View in: PubMed
    Score: 0.046
  31. Chronic Urticaria Patient Perspective (CUPP): The First Validated Tool for Assessing Quality of Life in Clinical Practice. J Allergy Clin Immunol Pract. 2018 Jan - Feb; 6(1):208-218.
    View in: PubMed
    Score: 0.046
  32. Asthma control in primary care: the results of an observational cross-sectional study in Italy and Spain. World Allergy Organ J. 2017; 10(1):13.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.